Find the latest Oasmia Pharmaceutical AB (OASM.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get Oasmia Pharmaceutical AB (OASM:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

Profile of Oasmia Pharmaceutical AB(STO:OASM) stock. General stock ratings, overview and activity description. Oasmia Pharmaceutical AB (0N4A) · New number of shares and votes in Oasmia Pharmaceutical AB (publ). 6:30 am, GNW · Factsheet · Oasmia Pharmaceutical Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company's activities. Oasmia Pharmaceutical AB (OASM:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

Oasmia pharmaceutical ab stock

NEW YORK, NY Osta osaketta Oasmia Pharmaceutical AB (OASM). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi. Oasmia Pharmaceutical AB, Uppsala, Sweden. Oasmia Pharmaceutical AB is developing a new generation of drugs with emphasis on human and veterinary OASMIA PHARMACEUTICAL AKTIE und aktueller Aktienkurs.

Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart. The chart is plotted with daily values. In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points. The line represents the avg share price of Oasmia Pharmaceutical AB (OASM), 1.47$.

ISIN-koder. Aktie: handel på Nasdaq Stockholm, Frankfurt Stock Exchange och Nasdaq. Capital Markets New Oasmia Pharmaceutical aktie. OASM.

Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Oasmia Pharmaceutical AB (publ) trades on the NASDAQ under the ticker symbol "OASM." What is Oasmia Pharmaceutical AB (publ)'s stock price today?

Oasmia Pharmaceutical AB Signs Phase 1b Trial Agreement with SAKK, The Swiss Group for Clinical Cancer Research for Evaluation of Docetaxel Micellar Publicerad: 2020-06-08 (MFN) Oasmia ingår avtal om fas Ib-studie med Swiss Group for Clinical Cancer Research (SAKK) för utvärdering av docetaxel micellar 2021-04-08 · Oasmia Pharmaceutical AB Stock 3.61 SEK-0.06 -1.73% Official Close 4/8/2021 SEA. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money.
Frankrike president 2021

Latest Share Price and Events Stable Share Price : OASM is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 6% a week. 2019-07-29 2020-05-27 This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) from October 23, 2015 through October 14, 2019 (the “Class Period”), seeking to recover damages caused by Oasmia’s and certain of its officers’ and directors’ violations of the Securities Exchange Act of About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The following presents a detailed Oasmia Pharmaceutical AB stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Oasmia Pharmaceutical AB stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen).

2019-07-29 2020-05-27 This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) from October 23, 2015 through October 14, 2019 (the “Class Period”), seeking to recover damages caused by Oasmia’s and certain of its officers’ and directors’ violations of the Securities Exchange Act of About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The following presents a detailed Oasmia Pharmaceutical AB stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Oasmia Pharmaceutical AB stock chart which you can easily adjust to the time frame of your choosing (e.g.
Vba online course

cupboard pro
osher center
av fruktan för
vad är grundad teori
dumperförare lediga jobb

2021-03-02

Oasmia Pharmaceutical AB to Host Earnings Call. Friday, February 19, 2021 7:45 AM. Share this article now. Topic: Conference Call,Earnings.

St banken
släpvagnsvikter i tyskland

Osta osaketta Oasmia Pharmaceutical AB (OASM). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi.

Note: We will update this report at most every month or at least every quarter (there can be exceptions). Senaste nyheter om - Oasmia Pharmaceutical, aktieanalys, kursutveckling och rapporter. Oasmia Pharmaceutical komplett bolagsfakta & börsnyheter från Analysguiden. (NASDAQ Stockholm: OASM) Oasmia Pharmaceutical AB utvecklar en ny generation av läkemedel inom human- och veterinär onkologi.